PREMIER Biosoft Launches SimMet for Analysis of MS Metabolite data
News May 27, 2014
PREMIER Biosoft announced the worldwide launch of its new informatics tool, SimMet. The launch coincides with the 62nd ASMS conference at Baltimore, Maryland. SimMet's comprehensive platform eliminates the need of managing and using multiple tools for metabolite research. All standard vendor formats are supported to seamlessly integrate qualitative and quantitative workflow solutions.
SimMet is engineered to effectively handle massive volumes of data which are typical of mass spectrometry based metabolomics workflows. It automates LC-MS data processing methods such as peak detection and peak picking besides retention time alignment and differential analysis across multiple biological samples.
The program enables users to identify metabolites using MS and MS/MS data in batch mode. All the results are displayed through interactive and intuitive graphical user interfaces. Users can view metabolite structures along with corresponding information, annotated MS and MS/MS spectra, overlay of extracted ion chromatograms for a compound across samples, statistical analysis results in single workspace which helps them to quickly extract meaningful information from their data.
"SimMet is another great addition to our strong portfolio of MS informatics tools for lipidomics and glycomics. A wide range of applications, including typical solutions for clinical, environmental and academic environments, have been included in SimMet to support targeted and non targeted analyses to address the metabolomic and biochemical profiling markets." said Arun Apte, CEO at PREMIER Biosoft.
Sysmex Partners with Laboratories to Deliver Improved QC ManagementNews
Sysmex America has announced its latest innovation: a way to make quality assurance easier and more risk free than manual quality control processes.READ MORE
BMS, QIAGEN Partner to Develop Gene Expression Profiles for Immuno-OncologyNews
QIAGEN and Bristol-Myers Squibb intend to develop GEPs for several Bristol-Myers Squibb I-O molecules under the initial agreement.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018
EMBL Course: RNA Sequencing Library Preparation - How Low Can You Go?
Mar 19 - Mar 23, 2018
EMBL Course: Analysis and Integration of Transcriptome and Proteome Data
Mar 12 - Mar 16, 2018
EMBO | EMBL Symposium: Tissue Self-Organisation: Challenging the Systems
Mar 11 - Mar 14, 2018